In a xenograft model of ovarian cancer, dual targeting of VEGF and Ang has been shown to result in greater inhibition of tumor angiogenesis and metastasis than monotherapy with either VEGF or Ang inhibitors167. This evidence concerns the gene VEGFA and ovarian carcinoma.